Castleman disease
Castleman disease (CD) (also known as angiofollicular lymph node hyperplasia or giant lymph node hyperplasia ) is an uncommon benign lymphoproliferative condition. It can affect several regions of the body although commonly described as a solitary mediastinal mass.
Epidemiology
The condition can potentially present at any age but typically presents in the 3rd to 4th decades.
Pathology
The disease is of unknown etiology but the most widely accepted theory is that Castleman's disease is a chronic low-grade inflammatory process.
The disease is characterised by hypervascular lymphoid hyperplasia. There are two distinct sub-types of Castleman disease : uni-centric (UCD) and multi-centric (MCD). Uni-centric disease is more common
There are also two recognised sub types based on histology 1,2
-
hyaline vascular :
- commoner ~ 90%
- more uni-centric
-
plasma cell :
- often multi-centric
- less enhancing
- may be more symptomatic 5
Location
The distribution is as follows :
- thorax : ~ 70 %
- abdomen / pelvis and retroperitoneum : ~ 10 - 15 %
- neck : 10 - 15 %
Multi-centric disease may involve all of the above, and is associated with a more complex clinical course and poorer prognosis.
Associations
- POEMS syndrome
- osteosclerotic myeloma
- Kaposi sarcoma
- AIDS - espacially multicentric 9
- amyloidosis10
Radiographic features
CT
For mediastinal lesions : CT chest
- commonly seen as a mediastinal mass and rarely as matted lymphadenopathy (with or without a dominant mass) in a single mediastinal compartment
- typical arborising calcification may be seen within the mass
- typically shows intense homogeneous enhancement following contrast
- dynamic CT demonstrates early rapid enhancement with washout in the delayed phase
For abdominal lesions : CT abdomen
- most commonly, a single well defined abdominal mass
- location is variable, and includes retroperitoneum, mesentery and porta hepatis 3
- enhancement is homogeneous, or in larger lesions ( > 5cm) may demonstrate central hypo-attenuation consistent with necrosis.
- variable pattern of calcification, including arborising calcification.
For multi-centric disease : multi-region CT
- bilateral hilar and mediastinal lymphadenopathy
- centrilobular nodules
- diffuse abdominal lymphadenopathy
- hepatosplenomegaly
- ascites
MRI
General signal characteristics include
- T1 : iso to hyper intense relative to skeletal muscle
- T1 C+ (Gd) : shows enhancement
- T2 : arborsing calcification may be seen as low signal
FDG - PET
There is some evidence that Castleman disease is FDG avid, and therefore 18F-FDG PET may be useful in identifying the extent of multi-centric disease and for monitoring disease progression 7.
Treatment and prognosis
For unicentric Castleman disease treatment is surgical, with good prognosis (can be curative).
Multicentric Castleman disease may be treated with any combination of surgery, chemotherapy and prednisolone 6. Prognosis is relatively poorer.
Etymology
The condition was first published by Benjamin Castleman in 1954 4
Differential diagnosis
For thoracic lesions consider
- If antero-superior : consider : differential for an antero-superior medistinal mass
- If posterior : consider : differential for a posterior medistinal mass

Details successfully updated.
Unable to process the form. Check for errors and try again.